KANSAS CITY, MO – OCTOBER 25: Running back Larry Johnson #27 of the Kansas City Chiefs watches the scoreboard during the game against the San Diego Chargers on October 25, 2009 at Arrowhead Stadium in Kansas City, Missouri. (Photo by Jamie Squire/Getty Images)Penn State is struggling against Michigan on Saturday, and fans are starting to get frustrated with how the team has performed in big games this season. One such fan is former Nittany Lion running back Larry Johnson.Johnson, who starred at Penn State from 1999-2002 and later had a great NFL career, took to Twitter with some interesting thoughts on the team’s coaching staff. It looks like he wants to see changes.Specifically, Johnson wants to see some position coaches fired. He isn’t saying which ones – but he is saying that he’s seeing the same issues each of the past three years.Here’s what Johnson, whose father was once a position coach at Penn State, had to say:? Amateur hour!— Larry Johnson (@2LarryJohnson7) November 3, 2018To be honest. These are the games that show you what position coach needs to be fired.— Larry Johnson (@2LarryJohnson7) November 3, 2018No. Just the ones getting exposed for the 3rd year straight.— Larry Johnson (@2LarryJohnson7) November 3, 2018To be clear, it doesn’t look like Johnson is advocating that James Franklin is the issue. He thinks some tweaks need to be made to the staff.Johnson, after a stellar senior season at Penn State, wound up going No. 27 overall to the Kansas City Chiefs. He played for the Chiefs for seven seniors – two of which were all-timers. He later played for the Bengals, Redskins and Dolphins as well.
In this 2006 photo, a technician at Ortho-Clinical Diagnostics Inc., works in a “sterile filling” room at the plant in Raritan, N.J. THE CANADIAN PRESS/AP, files AddThis Sharing ButtonsShare to TwitterTwitterShare to FacebookFacebookShare to RedditRedditShare to 電子郵件Email by Linda A. Johnson, The Associated Press Posted Jan 16, 2014 6:24 am MDT J&J receives $4.15 billion offer for Ortho-Clinical Diagnostics business from Carlyle Group TRENTON, N.J. – Johnson & Johnson said Thursday that it’s been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses.J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the offer. Johnson & Johnson executives plan to discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing the unit’s employees before making a decision.The Ortho-Clinical business serves hospitals, testing laboratories and blood banks.One division supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases, and for typing donated blood to ensure patients get safe, compatible blood transfusions. The other division makes technology for advanced testing of blood to diagnose a range of health conditions and to monitor the effects of medication.Established in 1937, Ortho Clinical Diagnostics is based in Raritan, N.J., and has factories in Rochester, N.Y.; Pompano Beach, Fla., and Pencoed, Wales. It has more than 4,500 employees and operates in more than 30 countries worldwide.Last January, CEO Alex Gorsky said J&J was looking at strategic options for Ortho-Clinical Diagnostics, which doesn’t meet the company’s long-held strategy of focusing on businesses that rank first or second in their markets.In 2012, J&J reported revenue of $2.1 billion for the diagnostics business, down more than 4 per cent from 2011. Revenue fell even more over the first nine months of 2013, when it was down 8 per cent from the prior year at $1.42 billion.Carlyle Group is a private equity and buyout firm based in Washington, D.C. If the sale goes through, Carlyle is expected to try to expand the business through increased marketing and creation of new products. Carlyle manages more than $185 billion worth of assets worldwide, according to its website.In afternooon trading, Carlyle shares were up 1 cent at $37. Johnson & Johnson shares were down 25 cents at $94.55. The stock has seen a tremendous run-up since Gorsky took over in April 2012, with shares rising 46 per cent from $64.75 back then.___AP Business Writer Tom Murphy in Indianapolis contributed to this report.